Jonan Boto
Advertisement
Jonan Boto is a Director for Kin + Carta Advise.
Articles by Jonan Boto
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
The GLP-1 Gold Rush
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
